Literature DB >> 7698894

Essential thrombocytemia and ischemic stroke: report of six cases.

L Casto1, M Camerlingo, G Finazzi, B Censori, T Barbui, A Mamoli.   

Abstract

Essential thrombocytemia (ET) is a clonal myeloproliferative disorder of unknown cause, characterized by an increased number of apparently normal platelets. It has been related to a large number of mild ischemic complications, but rarely to acute stroke associated with documented large vessel thrombosis. We report the cases of 6 patients with acute ischemic stroke associated with ET (4 men and 2 women; mean age 61.7: range 49-78 years). The diagnosis of ET followed the onset of the stroke. The number of platelets was never greatly increased at the time of the stroke, and two patients presented no major risk factors for stroke. The involvement of the posterior circulation was observed in three patients, that of the anterior circulation in two patient and that of the border territory in one. The obstruction of large intracranial or extracranial vessels was detected in all of the patients, and all of them were treated with antiplatelet agents (aspirin or ticlopidine). The outcome was good in 3 patients, fair in one and bad in two. We retain that ET might be a cause of acute ischemic stroke as a result of large vessel obstruction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7698894     DOI: 10.1007/bf02339933

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  15 in total

1.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

Review 2.  Essential thrombocythemia.

Authors:  A I Schafer
Journal:  Prog Hemost Thromb       Date:  1991

Review 3.  [Internal carotid occlusion and essential thrombocythemia. 2 cases].

Authors:  J P Muller; A Destee; A Verier; J Goudemand; F Bauters; P Warot
Journal:  Rev Neurol (Paris)       Date:  1990       Impact factor: 2.607

4.  Slowly progressive ischemic stroke as first manifestation of essential thrombocythemia.

Authors:  G Benassi; P Ricci; F Calbucci; F M Cacciatore; R D'Alessandro
Journal:  Stroke       Date:  1989-09       Impact factor: 7.914

5.  Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Authors:  S Murphy; H Iland; D Rosenthal; J Laszlo
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

6.  Aspirin ingestion in primary thrombocythemia.

Authors:  A Hattori; M Sanada; R Nagayama; A Shibata; M Okuma
Journal:  Thromb Haemost       Date:  1982-08-24       Impact factor: 5.249

7.  Transient neurologic and ocular manifestations in primary thrombocythemia.

Authors:  J J Michiels; P J Koudstaal; A H Mulder; H H van Vliet
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

8.  Neurologic manifestations of essential thrombocythemia.

Authors:  J Jabaily; H J Iland; J Laszlo; E W Massey; G B Faguet; J Brière; S A Landaw; A V Pisciotta
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

9.  Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

Authors:  S Cortelazzo; P Viero; G Finazzi; A D'Emilio; F Rodeghiero; T Barbui
Journal:  J Clin Oncol       Date:  1990-03       Impact factor: 44.544

10.  Platelet hyperaggregability and thrombosis in patients with thrombocythemia.

Authors:  K K Wu
Journal:  Ann Intern Med       Date:  1978-01       Impact factor: 25.391

View more
  3 in total

1.  Platelets, alcohol consumption, and onset of brain infarction.

Authors:  H Numminen; M Hillbom; S Juvela
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

2.  Cerebral haemorrhage as the presenting feature of myeloproliferative disorder.

Authors:  Jyothi Kondlapudi; Rory J O'Connor; Samantha Mawer
Journal:  BMJ Case Rep       Date:  2009-03-26

3.  Cardiovascular Manifestations of Myeloproliferative Disorders: A Review of the Literature.

Authors:  Muhammad Wasif Saif; Umer Khan; Bernard R Greenberg
Journal:  Hosp Physician       Date:  1999-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.